Test ID: HYOX
Hyperoxaluria Panel, Urine
Useful For
Suggests clinical disorders or settings where the test may be helpful
Distinguishing between primary and secondary hyperoxaluria
Distinguishing between type I and type II primary hyperoxaluria
Genetics Test Information
Provides information that may help with selection of the correct test or proper submission of the test request
Distinguishing between primary and secondary hyperoxaluria.
Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Increased urinary oxalate frequently leads to renal stone formation. Identification of the cause of increased urinary oxalate is important in the evaluation of the patient with renal oxalate stones or renal insufficiency due to hyperoxaluria and has important implications in therapy and prognosis.
Hyperoxalurias have been classified as primary (genetically determined) and secondary. Primary hyperoxalurias are rare autosomally inherited genetic diseases. Type I, a deficiency of peroxisomal alanine:glyoxylate transaminase, is characterized by increased urinary oxalic, glyoxylic, and glycolic acids. Some type I hyperoxaluric patients respond to supplementary pyridoxine therapy. Type II is due to a defect in hydroxypyruvate metabolism (D-glyceric acid dehydrogenase deficiency) and is characterized by an increase in urinary oxalic and glyceric acids.
Secondary hyperoxalurias are due to hyperabsorption of oxalate (enteric hyperoxaluria); total parenteral nutrition in premature infants; ingestion of oxalate, ascorbic acid, or ethylene glycol; or pyridoxine deficiency and may respond to appropriate therapy.
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
GLYCOLATE
0-31 days: 0-57 mg/g creatinine
1-5 months: 0-54 mg/g creatinine
6-12 months: 0-60 mg/g creatinine
1-5 years: 0-89 mg/g creatinine
> or =6 years: 0-78 mg/g creatinine
GLYCERATE
0-31 days: 0-38 mg/g creatinine
1-5 months: 0-71 mg/g creatinine
6-12 months: 0-56 mg/g creatinine
1-5 years: 0-17 mg/g creatinine
> or =6 years: 0-8 mg/g creatinine
OXALATE
0-31 days: 0-301 mg/g creatinine
1-5 months: 0-398 mg/g creatinine
6-12 months: 0-280 mg/g creatinine
1-5 years: 0-128 mg/g creatinine
6-10 years: 0-72 mg/g creatinine
> or =11 years: 0-56 mg/g creatinine
GLYOXYLATE
0-31 days: 0.0-7.9 mg/g creatinine
1-5 months: 0.0-11.4 mg/g creatinine
6-12 months: 0.0-5.5 mg/g creatinine
1-5 years: 0.0-3.9 mg/g creatinine
> or =6 years: 0.0-2.9 mg/g creatinine
Interpretation
Provides information to assist in interpretation of the test results
Increased concentrations of oxalate and glycolate indicate type I hyperoxaluria.
Increased concentrations of oxalate and glycerate indicate type II hyperoxaluria.
Increased concentrations of oxalate with normal concentrations of glycolate and glycerate indicate secondary hyperoxaluria.
Cautions
Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
Ascorbic acid will falsely elevate oxalic acid results.
Clinical Reference
Provides recommendations for further in-depth reading of a clinical nature
1. Monico CG, Persson M, Ford GC, et al: Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002;62:392-400
2. Danpure CJ: Primary hyperoxaluria. In The Metabolic Bases of Inherited Disease. 8th edition. Edited by CR Scriver, AL Beaudet, WS Sly, et al. New York, McGraw-Hill Book Company, 2001, pp 3323-3367
3. Byrd DJ, Latta K: Hyperoxaluria. In Physician’s Guide to the Laboratory Diagnosis of Metabolic Disease. Edited by N Blau, ED Chapman. Hall Medical, 1996, pp 377-390
4. Fraser AD: Importance of glycolic acid analysis in ethylene glycol poisoning. Clin Chem 1998;44(8):1769


